CyBeR Association in Relapsed/Refractory DLBCL

NCT02758925 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: Bendamustine
DRUG: Cytarabine

Sponsor

University Hospital, Caen